|
Capital Fund Iv Cooperatief U.a. Forbion
|
10% or greater ownership |
|
Capital Life Sciences Fund Ii, L.p. Bain
|
10% or greater ownership |
|
Capital Life Sciences Fund Iii, L.p. Bain
|
10% or greater ownership |
|
Capital Life Sciences Iii General Partner, Llc Bain
|
10% or greater ownership |
|
Capital Life Sciences Investors Ii, Llc Bain
|
10% or greater ownership |
|
Capital Life Sciences Investors, Llc Bain
|
10% or greater ownership |
|
Der Kamp Hilde Johanna Van
|
Director |
|
Douglas F Kling
|
Chief Operating Officer |
|
Fund Iii Investments Gp, Llc Bcls
|
10% or greater ownership |
|
Fund Iii Investments, Lp Bcls
|
10% or greater ownership |
|
Growth Management B.v. Forbion
|
10% or greater ownership |
|
Growth Opportunities Fund I Cooperatief U.a. Forbion
|
10% or greater ownership |
|
Hugo Alexander Slootweg
|
Director |
|
Ii Investco (gp), Llc Bcls
|
10% or greater ownership |
|
Ii Investco, Lp Bcls
|
10% or greater ownership |
|
Iv Management B.v. Forbion
|
10% or greater ownership |
|
James N Topper
|
Director |
|
Johannes Jacob Pieter Kastelein
|
Chief Scientific Officer, Director |
|
John W Smither
|
Director |
|
Juliette Berangere Audet
|
Chief Business Officer |
|
Life Sciences Associates, Lp Bcip
|
10% or greater ownership |
|
Louis G Lange
|
Director |
|
Louise Frederika Kooij
|
Chief Accounting Officer |
|
Mark C. Mckenna
|
Director |
|
Mayur Ian Somaiya
|
Chief Financial Officer |
|
Michael H. Davidson
|
Chief Executive Officer, Director |
|
Nap B.v. Forgrowth
|
10% or greater ownership |
|
Nicholas Downing
|
Director |
|
William A Jr Jones
|
Chief Commercial Officer |
|
William Lewis
|
Director |
|
Wouter Joustra
|
Director |
